These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
293 related articles for article (PubMed ID: 21640148)
21. Optimizing microneedle arrays for transdermal drug delivery: extension to non-square distribution of microneedles. Al-Qallaf B; Das DB J Drug Target; 2009 Feb; 17(2):108-22. PubMed ID: 19016071 [TBL] [Abstract][Full Text] [Related]
22. Optimizing microneedle arrays to increase skin permeability for transdermal drug delivery. Al-Qallaf B; Das DB Ann N Y Acad Sci; 2009 Apr; 1161():83-94. PubMed ID: 19426308 [TBL] [Abstract][Full Text] [Related]
23. Transdermal delivery of relatively high molecular weight drugs using novel self-dissolving microneedle arrays fabricated from hyaluronic acid and their characteristics and safety after application to the skin. Liu S; Jin MN; Quan YS; Kamiyama F; Kusamori K; Katsumi H; Sakane T; Yamamoto A Eur J Pharm Biopharm; 2014 Feb; 86(2):267-76. PubMed ID: 24120887 [TBL] [Abstract][Full Text] [Related]
24. Recent advances in microneedle-based drug delivery: Special emphasis on its use in paediatric population. Duarah S; Sharma M; Wen J Eur J Pharm Biopharm; 2019 Mar; 136():48-69. PubMed ID: 30633972 [TBL] [Abstract][Full Text] [Related]
25. Facial skin barrier function recovery after microneedle transdermal delivery treatment. Han TY; Park KY; Ahn JY; Kim SW; Jung HJ; Kim BJ Dermatol Surg; 2012 Nov; 38(11):1816-22. PubMed ID: 22882208 [TBL] [Abstract][Full Text] [Related]
27. Production of dissolvable microneedles using an atomised spray process: effect of microneedle composition on skin penetration. McGrath MG; Vucen S; Vrdoljak A; Kelly A; O'Mahony C; Crean AM; Moore A Eur J Pharm Biopharm; 2014 Feb; 86(2):200-11. PubMed ID: 23727511 [TBL] [Abstract][Full Text] [Related]
29. A simple method of microneedle array fabrication for transdermal drug delivery. Kochhar JS; Goh WJ; Chan SY; Kang L Drug Dev Ind Pharm; 2013 Feb; 39(2):299-309. PubMed ID: 22519721 [TBL] [Abstract][Full Text] [Related]
30. Evaluation needle length and density of microneedle arrays in the pretreatment of skin for transdermal drug delivery. Yan G; Warner KS; Zhang J; Sharma S; Gale BK Int J Pharm; 2010 May; 391(1-2):7-12. PubMed ID: 20188808 [TBL] [Abstract][Full Text] [Related]
31. Membrane-sealed hollow microneedles and related administration schemes for transdermal drug delivery. Roxhed N; Griss P; Stemme G Biomed Microdevices; 2008 Apr; 10(2):271-9. PubMed ID: 17940907 [TBL] [Abstract][Full Text] [Related]
32. Fabrication and characterisation of self-applicating heparin sodium microneedle patches. Arshad MS; Zafar S; Zahra AT; Zaman MH; Akhtar A; Kucuk I; Farhan M; Chang MW; Ahmad Z J Drug Target; 2021 Jan; 29(1):60-68. PubMed ID: 32649227 [TBL] [Abstract][Full Text] [Related]
33. Modelling transdermal delivery of high molecular weight drugs from microneedle systems. Al-Qallaf B; Das DB; Mori D; Cui Z Philos Trans A Math Phys Eng Sci; 2007 Dec; 365(1861):2951-67. PubMed ID: 17890186 [TBL] [Abstract][Full Text] [Related]
34. Challenges and strategies in developing microneedle patches for transdermal delivery of protein and peptide therapeutics. Wu F; Yang S; Yuan W; Jin T Curr Pharm Biotechnol; 2012 Jun; 13(7):1292-8. PubMed ID: 22201589 [TBL] [Abstract][Full Text] [Related]
35. Development and comparison of machine learning models for in-vitro drug permeation prediction from microneedle patch. Biswas AA; Dhondale MR; Singh M; Agrawal AK; Muthudoss P; Mishra B; Kumar D Eur J Pharm Biopharm; 2024 Jun; 199():114311. PubMed ID: 38710374 [TBL] [Abstract][Full Text] [Related]